Claus Andersson
Investment Director, Sunstone Capital - Life Sciences

Dr. Claus Andersson is an investment director in the life sciences team at Sunstone Capital. He has over 12 years of industrial experience and more than 8 years of venture capital experience in the biotechnology industry. Dr. Andersson holds a PhD in multivariate statistics, which he obtained in the department of Prof. Dr. Bro at the University of Copenhagen and Humboldt University, Berlin. He has published more than 17 peer reviewed scientific publications in applied mathematics. While obtaining his PhD, Dr. Andersson served as manager in Radiometer Medical A/S which he left in 2001 to start a company and has subsequently founded and co-founded four additional companies and a smaller ICT venture fund. Dr. Andersson has served on numerous boards and is currently also a member of Jurag Separation A/S, PreciSense A/S (acquired by Medtronic Inc.), ScanCell ApS (Chair) and Equinostic ApS (Chair). Dr. Andersson has been an observer to the Board of Directors of Santaris Pharma A/S since 2006 and was appointed as a board member in 2010.